Endocrinology

Your Article Summary

See Latest Articles

Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients—The PREDICTIVE BMI clinical trial
Diabetic Medicine, 08/20/08

Montanana C et al. - PREDICTIVE BMI was the first study to examine the effect of once-daily detemir with weight as the primary endpoint in a large population of overweight Type 2 diabetes patients. Use of once-daily detemir for intensification of insulin therapy resulted in less weight gain, less hypoglycaemia and equivalent glycaemic control compared with NPH.

Today in Diabetes...keeping you current

Receive free subspecialty "5-minute updates" via email

Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/17/09

Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes
The American Journal of the Medical Sciences, 12/17/09

Ileal Interposition with Sleeve Gastrectomy for Control of Type 2 Diabetes
Diabetes Technology & Therapeutics, 12/17/09

 See all of Diabetes

Today in Pharmacology/kinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/17/09

Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/17/09

Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
Diabetes Technology & Therapeutics, 12/17/09

 See all of Pharmacology/kinetics